Valuation: CellaVision AB

Market Cap 485.38Cr 48Cr 44Cr 40Cr 36Cr 69Cr 4.51TCr 71Cr 192.32Cr 2.42TCr 180.43Cr 176.61Cr 7.67TCr P/E 2026 *
33.6x
P/E 2027 * 26x
Enterprise Value 465.49Cr 46Cr 42Cr 39Cr 35Cr 66Cr 4.33TCr 68Cr 184.44Cr 2.32TCr 173.04Cr 169.37Cr 7.36TCr EV / Sales 2026 *
5.91x
EV / Sales 2027 * 5.21x
Free-Float
81.06%
Yield 2026 *
1.35%
Yield 2027 * 1.57%
1 day+1.23%
1 week+1.72%
Current month+5.57%
1 month+24.40%
3 months+36.39%
6 months+68.16%
Current year+31.36%
1 week 198.8
Extreme 198.8
207
1 month 162.2
Extreme 162.2
207
Current year 117.6
Extreme 117.6
207
1 year 117.6
Extreme 117.6
207
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
394.5
10 years 77.75
Extreme 77.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Buy

Chief Executive Officer

8,077 0.0339%
02/09/26 Free 1,00,000 0.4193%
28/04/26 Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%+1.72%+30.70%+23.50% 48Cr
-1.27%-4.20%+19.46%+46.32% 26TCr
-1.33%-2.22%+3.93%+9.95% 16TCr
-1.32%-4.95%-20.34%+44.02% 15TCr
-1.47%-0.75%-57.45%-20.08% 6.33TCr
-0.04%+2.29%+24.11%+58.75% 6.16TCr
-1.22%+1.37%+4.19%-13.01% 5.39TCr
-0.60%-4.02%+17.78%+51.43% 4.88TCr
-0.75%-2.32%+2.02%+70.70% 4.85TCr
-1.48%-4.88%+19.51%+70.33% 4.46TCr
Average -0.34%-0.09%+4.39%+34.19% 9TCr
Weighted average by Cap. -0.02%-0.31%+2.76%+34.67%

Financials

2026 *2027 *
Net sales 79Cr 7.8Cr 7.09Cr 6.55Cr 5.92Cr 11Cr 732.61Cr 12Cr 31Cr 393.14Cr 29Cr 29Cr 1.25TCr 88Cr 8.76Cr 7.95Cr 7.35Cr 6.64Cr 13Cr 822.15Cr 13Cr 35Cr 441.2Cr 33Cr 32Cr 1.4TCr
Net income 14Cr 1.43Cr 1.3Cr 1.2Cr 1.09Cr 2.05Cr 134.59Cr 2.12Cr 5.73Cr 72Cr 5.38Cr 5.26Cr 228.78Cr 19Cr 1.85Cr 1.68Cr 1.55Cr 1.4Cr 2.65Cr 173.61Cr 2.74Cr 7.4Cr 93Cr 6.94Cr 6.79Cr 295.1Cr
Net Debt -20Cr -1.97Cr -1.79Cr -1.65Cr -1.49Cr -2.82Cr -184.96Cr -2.92Cr -7.88Cr -99Cr -7.39Cr -7.24Cr -314.4Cr -25Cr -2.5Cr -2.27Cr -2.1Cr -1.89Cr -3.58Cr -234.66Cr -3.7Cr -10Cr -125.93Cr -9.38Cr -9.18Cr -398.88Cr
Projected Income Statement - Annual - CellaVision AB
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
252
Date Price Change Volume
17/26/17 SEK 207.00 +1.72% 9,414
16/26/16 SEK 203.50 0.00% 30,486
13/26/13 SEK 203.50 +0.74% 23,441
12/26/12 SEK 202.00 -0.25% 23,856
11/26/11 SEK 202.50 -0.25% 19,309
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - CellaVision AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
203.50SEK
Average target price
198.33SEK
Spread / Average Target
-2.54%
  1. Stock Market
  2. Stocks
  3. CEVI Stock